Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details)

v3.21.1
Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net revenue $ 29,768 $ 21,867
Direct operating costs 18,060 13,567
Selling and marketing 1,890 1,581
General and administrative 5,624 5,593
Research and development 2,026 2,333
Depreciation and amortization 2,831 1,333
Impairment and unoccupied lease charges 1,018 297
Total operating expenses 31,449 24,704
Operating (loss) income (1,681) (2,837)
Healthcare IT [Member]    
Net revenue 27,033 18,841
Direct operating costs 15,987 11,166
Selling and marketing 1,882 1,572
General and administrative 3,426 3,881
Research and development 2,026 2,333
Depreciation and amortization 2,749 1,254
Impairment and unoccupied lease charges 1,018 297
Total operating expenses 27,088 20,503
Operating (loss) income (55) (1,662)
Practice Management [Member]    
Net revenue 2,735 3,026
Direct operating costs 2,073 2,401
Selling and marketing 8 9
General and administrative 520 556
Research and development
Depreciation and amortization 82 79
Impairment and unoccupied lease charges
Total operating expenses 2,683 3,045
Operating (loss) income 52 (19)
Unallocated Corporate Expenses [Member]    
Net revenue
Direct operating costs
Selling and marketing
General and administrative 1,678 1,156
Research and development
Depreciation and amortization
Impairment and unoccupied lease charges
Total operating expenses 1,678 1,156
Operating (loss) income $ (1,678) $ (1,156)